With the exploration and innovation of company people, gradually formed four major advantageous products: steel plate, steel pipe, stainless steel, special steel.
TRACRIUM (atracurium besylate) is contraindicated in patients known to have a hypersensitivity to it. Use of TRACRIUM (atracurium besylate) from multiple-dose vials containing benzyl alcohol as a preservative is contraindicated in patients with a known hypersensitivity to benzyl alcohol.
Atracurium Besylate is a synthetic dibenzensulfonate derivative muscle relaxant, Atracurium Besylate acts as a non-depolarizing neuromuscular blocking agent, with short to intermediary duration of action and no significant cardiovascular effects.
For continuous IV infusion, dilute atracurium besylate injection to the desired concentration (usually 0.2 or 0.5 mg/mL) in 5% dextrose, 5% dextrose and 0.9% sodium chloride, or 0.9% sodium chloride injection. 1 Use within 24 hours. 1. Dosage. Available as atracurium besylate; dosage expressed in terms of the salt. 1
Find patient medical information for Atracurium Intravenous on WebMD including its uses, side effects and safety, interactions, pictures, warnings and user ratings.
Identification Name Atracurium besylate Accession Number DB00732 (APRD00806) Type Small Molecule Groups Approved Description. A non-depolarizing neuromuscular blocking agent with short duration of action.
ATRACURIUM Besylate Injection, USP . Brand Name Equivalent: TRACRIUM (TRACRIUM is a atracurium besylate
General description This product is provided as delivered and specified by the issuing Pharmacopoeia. All information provided in support of this product, including SDS and any product information leaflets have been developed and issued under the Authority of the issuing Pharmacopoeia.For further information and support please go to the website of the issuing Pharmacopoeia.
Indications, dose, contra-indications, side-effects, interactions, cautions, warnings and other safety information for ATRACURIUM BESILATE.
As is evident with the parent molecule, atracurium, cisatracurium is also susceptible to degradation by Hofmann elimination and ester hydrolysis as components of the in vivo metabolic processes.  See the atracurium page for information on Hofmann elimination in vivo versus the Hofmann degradation chemical reaction.
(cisatracurium besylate) Injection. DESCRIPTION. NIMBEX (cisatracurium besylate) is a nondepolarizing skeletal neuromuscular blocker for intravenous administration. Compared to other neuromuscular blockers, it is intermediate in its onset and duration of action. Cisatracurium besylate is one of 10 isomers of atracurium besylate and constitutes atracurium besylate
Atracurium Besylate Injection, USP. Brand Name Equivalent: Tracrium. Return to Products Listing PRINT PRODUCTS PACKAGE INSERTS SAFETY DATA SHEET WHOLESALER ITEM NUMBERS STORAGE CONDITIONS Atracurium Besylate Injection, USP 50 mg per 5 mL. Unit of atracurium besylate
Atracurium besylate infusion solutions may be prepared by admixing atracurium besylate injection with an appropriate diluent such as 5% Dextrose Injection, 0.9% Sodium Chloride Injection, or 5% Dextrose and 0.9% Sodium Chloride Injection. Infusion solutions should be used within 24 hours of preparation. Unused solutions should be discarded.
Atracurium Besylate Injection prescription and dosage sizes information for physicians and healthcare professionals. Pharmacology, adverse reactions, warnings and side effects.
Literature References: Benzylisoquinolinium, competitive neuromuscular blocker. Prepn: J. B. Stenlake et al., DE 2655883; eidem, US 4179507 (1977, 1979 both to atracurium besylate
Medscape - Indication-specific dosing for Tracrium (atracurium), frequency-based adverse effects, comprehensive interactions, contraindications, pregnancy & lactation schedules, and cost information.
ATRACURIUM BESYLATE INJECTION. Faulding . I.V. Skeletal Neuromuscular Blocking Agent . Action And Clinical Pharmacology: Atracurium is a nondepolarizing, intermediate-duration, skeletal neuromuscular blocking agent. Nondepolarizing agents antagonize the neurotransmitter action of acetylcholine by binding competitively to cholinergic receptor sites on the motor endplate.
AZD3839 New AZD3839 is a potent and selective BACE1 inhibitor with K i of 26.1 nM, about 14-fold selectivity over BACE2. Phase 1. Xanthohumol New Xanthohumol, a prenylated chalcone from hop, inhibits COX-1 and COX-2 activity and shows chemopreventive effects. Phase 1. A-438079 HCl New A-438079 HCl is a potent, and selective P2X7 receptor antagonist with pIC50 of 6.9.
Atracurium Besylate is a neuromuscular blocking agent with ED95 of 0.2 mg/kg. ;Target: nAChRAtracurium besylate is a neuromuscular-blocking drug or skeletal muscle relaxant in the category of non-depolarizing neuromuscular-blocking drugs, used adjunctively in anesthesia to facilitate endotracheal intubation and to provide skeletal muscle atracurium besylate
Rated 5 out of 5 by LM from Atracurium Besylate has been reported in Atracurium Besylate has been reported in many articles as a muscle relaxant with little cardiovascular effects and no dependence on good kidney function. -SCBT Publication Review
atracurium besylate: ( a-tr-kyr'-m b'sil-t' ), A nondepolarizing neuromuscular relaxant of intermediate duration of action; used as an adjunct to general anesthesia; a curarelike agent.
Drug Name Active Ingredients Strength Dosage Form/Route Marketing Status TE Code RLD RS; ATRACURIUM BESYLATE PRESERVATIVE FREE: ATRACURIUM BESYLATE: 10MG/ML
Alibaba.com offers 164 atracurium besylate products. About 19% of these are animal pharmaceuticals, 13% are anesthetic agents, and 11% are antineoplastic agents. A wide variety of atracurium besylate options are available to you, such as anesthetic agents, antineoplastic agents, and antibiotic and antimicrobial agents.
Intravenous. PREPARE: Direct: Give initial bolus dose undiluted. Continuous: Maintenance dose must be diluted with NS, D5W or D5/NS. Do not mix in same syringe or administer through same needle as used for alkaline solutions [incompatible with alkaline solutions (e.g., barbiturates)].
Cisatracurium Besylate Injection, USP is a nondepolarizing skeletal neuromuscular blocker for intravenous administration. Compared to other neuromuscular blockers, it is intermediate in its onset and duration of action. Cisatracurium besylate is one of 10 isomers of atracurium besylate and constitutes approximately 15% of that mixture.
Atracurium besylate is a neuromuscular blocking agent with ED95 of 0.2 mg/kg. Ordering online. To place an order online, simply browse to the product you are interested in and click on the 'Add to Cart' button.
NIMBEX (cisatracurium besylate) is a nondepolarizing skeletal muscle relaxant for intravenous administration. Compared to other neuromuscular blocking agents, it is intermediate in its onset and duration of action. Cisatracurium besylate is one of 10 isomers of atracurium besylate and constitutes approximately 15% of that mixture.
Technical Service: Our team of scientists has experience in all areas of research including Life Science, Material Science, Chemical Synthesis, Chromatography, Analytical and many others.
Why is DailyMed no longer displaying pill images on the Search Results and Drug Info pages? Due to inconsistencies between the drug labels on DailyMed and the pill images provided by RxImage, we no longer display the RxImage pill images associated with drug labels.. We anticipate reposting the images once we are able identify and filter out images that do not match the information provided in atracurium besylate
Cisatracurium besylate is the (1R,1'R,2R,2'R)-diastereoisomer of atracurium besylate.Commercial preparations of atracurium are mixtures of 10 stereoisomers, of which cisatracurium generally constitutes about 15%. Cisatracurium besylate is about 3 times more potent than the mixture of atracurium isomers as a neuromuscular blocking agent, and is used as a muscle relaxant for endotracheal atracurium besylate
atracurium besylate brand name, atracurium drip, atracurium besylate mechanism of action, injection atracurium, atracurium besylate injection, atracurium besylate side effects, atracurium package insert, atracurium besylate classification, atracurium dosage, atracurium besylate brand names, cisatracurium besylate, atracurium besylate drug study,
You may also leave contact information, we will contact you as soon as possible!